Atenolol and chlorthalidone and Torsemide interaction
Atenolol and chlorthalidone and Torsemide: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Atenolol and chlorthalidone label · effective 2025-09-22
Because of its relative beta 1 -selectivity, however, atenolol and chlorthalidone may be used with caution in patients with bronchospastic disease who do not respond to or cannot tolerate, other antihypertensive treatment.
Drug Interactions Atenolol and chlorthalidone may potentiate the action of other antihypertensive agents used concomitantly.
Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.
From the Torsemide label · effective 2026-07-21
Ototoxicity Tinnitus and hearing loss (usually reversible) have been observed with loop diuretics, including torsemide.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects; risk of renal impairment.
Organic Anion Drugs: May decrease diuretic activity of torsemide.
The antihypertensive and diuretic effects of torsemide can be reduced by NSAIDs.
Monitor diuretic effect and blood pressure when used in combination with CYP2C9 inhibitor or inducer.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.